Differences in CYP3A4*1G genotype distribution and haplotypes of CYP3A4, CYP3A5 and CYP3A7 in 3 Chinese populations

Clinica Chimica Acta

Volumn 383, Issue 1-2, 2007, Pages 172-174

  Du, Jing ^a,b   Yu, Lan ^a,b   Wang, Lei ^a,b   Zhang, Aiping ^a,b   Shu, Anli ^c   Xu, Lingyun ^d   Xu, Mingsheng ^e   Shi, Yongyong ^a,b   Li, Xingwang ^a,b   Feng, Guoyin ^f   Xing, Qinghe ^a,b   He, Lin ^a,b  

^a SHANGHAI JIAO TONG UNIVERSITY   (China)

^b Shanghai Jiao Tong University Affiliated Sixth People s Hospital   (China)

^c HUAIHUA MEDICAL COLLEGE   (China)

^d WANNAN MEDICAL COLLEGE   (China)

^e Anhui Institute of Parasitic Diseases   (China)

^f SHANGHAI MENTAL HEALTH CENTER   (China)

Author keywords

[No Author keywords available]

Indexed keywords

CYTOCHROME P450 3A4; CYTOCHROME P450 3A5; CYTOCHROME P450 3A7; SODIUM; CYP3A13 PROTEIN, MOUSE; CYP3A4 PROTEIN, HUMAN; CYP3A5 PROTEIN, HUMAN; CYTOCHROME P450; CYTOCHROME P450 3A; MEMBRANE PROTEIN; UNCLASSIFIED DRUG;

ADULT; CHINESE; DNA DETERMINATION; FEMALE; GENE FREQUENCY; GENOTYPE; HAPLOTYPE; HUMAN; LETTER; MALE; NORMAL HUMAN; POPULATION GENETICS; POPULATION RESEARCH; PRIORITY JOURNAL; RACE DIFFERENCE; CHINA; EPIDEMIOLOGY; ETHNOLOGY; GENETIC VARIABILITY; GENETICS;

CHINA; CYTOCHROME P-450 CYP3A; CYTOCHROME P-450 ENZYME SYSTEM; EPIDEMIOLOGY, MOLECULAR; MEMBRANE PROTEINS; VARIATION (GENETICS);

EID: 34347348991     PISSN: 00098981     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.cca.2007.04.027     Document Type: Letter

References (16)

1. Rendic S., and Di Carlo F.J. Human cytochrome P450 enzymes: a status report summarizing their reactions, substrates, inducers, and inhibitors. Drug Metab Rev 29 (1997) 413-580
2. Oesterheld J.R. A review of developmental aspects of cytochrome P450. J Child Adolesc Psychopharmacol 8 (1998) 161-174
3. Wojnowski L. Genetics of the variable expression of CYP3A in humans. Ther Drug Monit 26 (2004) 192-199
4. Nebert D.W., and Russell D.W. Clinical importance of the cytochromes P450. Lancet 360 (2002) 1155-1162
5. Tateishi T., Watanabe M., Moriya H., Yamaguchi S., Sato T., and Kobayashi S. No ethnic difference between Caucasian and Japanese hepatic samples in the expression frequency of CYP3A5 and CYP3A7 proteins. Biochem Pharmacol 57 (1999) 935-939
6. Westlind A., Malmebo S., Johansson I., et al. Cloning and tissue distribution of a novel human cytochrome p450 of the CYP3A subfamily, CYP3A43. Biochem Biophys Res Commun 281 (2001) 1349-1355
7. Du J., Xing Q., Xu L., et al. Systematic screening for polymorphisms in the CYP3A4 gene in the Chinese population. Pharmacogenomics 7 (2006) 831-841
8. Ahmadi K.R., Weale M.E., Xue Z.Y., et al. A single-nucleotide polymorphism tagging set for human drug metabolism and transport. Nat Genet 37 (2005) 84-89
9. Fukushima-Uesaka H., Saito Y., Watanabe H., et al. Haplotypes of CYP3A4 and their close linkage with CYP3A5 haplotypes in a Japanese population. Hum Mutat 23 (2004) 100
10. Lan Yu, Lei Wang, Jing Du et al. CYP3A5 polymorphisms in different Chinese populations. Curr Drug Metab submitted for publication.
11. Jing D., Yongyong S., Aiping Z., et al. Screening for SNP and haplotypes in the CYP3A7 gene in the Chinese population. Pharmacogenomics 8 6 (2007) 559-566
12. Dudbridge F. Pedigree disequilibrium tests for multilocus haplotypes. Genet Epidemiol 25 (2003) 115-121
13. Ball S.E., Scatina J., Kao J., et al. Population distribution and effects on drug metabolism of a genetic variant in the 5′ promoter region of CYP3A4. Clin Pharmacol Ther 66 (1999) 288-294
14. Zeigler-Johnson C., Friebel T., Walker A.H., et al. CYP3A4, CYP3A5, and CYP3A43 genotypes and haplotypes in the etiology and severity of prostate cancer. Cancer Res 64 (2004) 8461-8467
15. He P., Court M.H., Greenblatt D.J., and Von Moltke L.L. Genotype-phenotype associations of cytochrome P450 3A4 and 3A5 polymorphism with midazolam clearance in vivo. Clin Pharmacol Ther 77 (2005) 373-387
16. Rodriguez-Antona C., Jande M., Rane A., and Ingelman-Sundberg M. Identification and phenotype characterization of two CYP3A haplotypes causing different enzymatic capacity in fetal livers. Clin Pharmacol Ther 77 (2005) 259-270